drugset / Trial / NCT02155504

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects

NCT02155504

Phase 1 Completed 44 enrolled Astellas Pharma Europe B.V.
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics (PK) of single ascending oral doses of ASP3700 in healthy male subjects. This study will also explore the effect of itraconazole (another drug) on the PK of ASP3700, as well as to evaluate the safety and tolerability of ASP3700 alone and in combination with itraconazole in healthy male subjects.

Timeline

Start
2014-05
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ASP3700 Unknown Oral
Comparator Itraconazole Small molecule Oral

Indications

No indication recorded.